- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03149952
A Pilot Study of the Feasibility of Setting up a Logbook for Allogeneic Haematopoietic Stem Cell Patients at the University Hospital of Amiens (CABALLO)
Hospitalization for allogeneic haematopoietic stem cell transplantation constitutes a particular time in the management of patients with malignant hemopathies both for the patient, for his entourage or for the nursing staff. For the patient, the strict protective isolation set up during this period is a source of isolation in the broad sense and is associated with an escape from external events and society. It also constitutes a physical barrier (mask, charlotte, surblouse and overshoes worn by caregivers or visitors) and even psychological in relations with relatives. Moreover, this period is also difficult because of the possible complications of conditioning (mucositis, transit disorders, fever ...) and allograft itself (graft versus host disease, no transplant, relapse disease…). The patient may be weakened and diminished, which can give a feeling of helplessness and uselessness to the family. Finally, this therapy can have serious physical and psychological consequences for the patient and his entourage (especially in the case of family allograft) who do not always have the possibility to express themselves verbally. Published studies in hematology report depressive, anxious and post-traumatic stress disorders in patients and relatives during allogeneic haematopoietic stem cell transplantation. It is therefore important to reduce these symptoms, particularly those related to the cut-off during hospitalization for allogeneic haematopoietic stem cells.
Over the last decade or so, the logbook has been used in some resuscitation services in intubated patients, with the main objective of filling the "memory gap" mentioned by the intubated patients when they woke up and limiting the trauma associated with this Cut in the world corresponding to the sedation period. For this purpose, the use of a logbook in Hematology, by analogy with what is used in the resuscitation services, could be a means of limiting the psychological complications related to the allograft.
Study Overview
Status
Conditions
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Major hospitalized patient for allogeneic haematopoietic stem cells
- Patient agreeing to participate
Exclusion Criteria:
- Patient refusing to participate
- Patient hospitalized for reasons other than allogeneic haematopoietic stem cells
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patient hospitalized for allogeneic haematopoietic stem cells
|
Evaluation of the feasibility of the establishment of a logbook in patients hospitalized for allogeneic haematopoietic stem cells.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Analysis of the effectiveness of the logbook made available to hospitalized patients in hematology to limit the psychological complications related to the allograft.
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PI2016_843_0012
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Allogeneic Disease
-
University of AlbertaRecruitingAllogeneic DiseaseCanada
-
Central Hospital, Nancy, FranceSaint-Louis Hospital, Paris, FranceNot yet recruitingGraft Failure | GVHD,Acute | Allogeneic Disease
-
Dartmouth-Hitchcock Medical CenterRecruitingAllogeneic Stem-Cell TransplantUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...RecruitingStem Cell Transplant | AllogeneicUnited States
-
Medical University of GrazCompletedAllogeneic Stem Cell Transplantation
-
Children's Hospital Medical Center, CincinnatiTerminatedAllogeneic Hematopoietic Cell TransplantationUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedAllogeneic HCT SurvivorsUnited States
-
Children's Hospital Medical Center, CincinnatiRecruitingAllogeneic Hematopoietic Cell TransplantationUnited States
-
Case Comprehensive Cancer CenterRecruitingAllogeneic Hematopoietic Cell TransplantationUnited States
-
Mitchell Horwitz, MDPfizerTerminatedAllogeneic Stem Cell TransplantationUnited States
Clinical Trials on Evaluation of the feasibility of the establishment of a logbook in patients hospitalized for allogeneic haematopoietic stem cells
-
Jinnah Burn and Reconstructive Surgery Centre,...The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township... and other collaboratorsRecruitingRetinitis Pigmentosa (RP)Pakistan
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed
-
Tel-Aviv Sourasky Medical CenterRecruitingAtrial FibrillationIsrael
-
Hospices Civils de LyonUnknown
-
University of DerbyRecruitingOld Age; Debility | Stability | Balance; DistortedUnited Kingdom
-
University Hospital, BordeauxRecruiting
-
Federal Research Institute of Pediatric Hematology...Not yet recruitingAcute Lymphoblastic Leukemia, Pediatric | ALL, Infants
-
University Hospital, MontpellierNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterCompletedRectal CancerUnited States